Buprenorphine

Class: analgesic – opioid, partial mu agonist/weak kappa antagonist (partial agonist so ceiling effect to analgesia occurs)

Indications: moderate to severe pain

Contraindications/cautions: buprenorphine hypersensitivity/allergy, use with other opioids, adverse effects such as respiratory depression may not completely respond to naloxone, COPD, use with benzodiazepines; caution with MAOIs, hypotension, obstructive bowel disorders, hepatic impairment, renal impairment

Adverse reactions: see morphine

Metabolism/clearance: metabolised by unclear pathway

Interactions:

Dosing:
sublingual combo: not used
subcut: not used
patch: 5 to 20 micrograms/hour (each patch lasts for 3 to 7 days depending on brand). Start on 5 micrograms patch; increase if required every 3 days

Syringe driver: compatibility unknown so best to infuse on its own. Irritancy potential is unknown

Mechanism of action: partially stimulates mu- and blocks kappa opioid receptors in the CNS and gastrointestinal tract

Peak effect: patch: 60 hours after initial application

Onset: 11 to 21 hours

Duration: patch: 3 to 7 days – depending on brand

Notes:

Link Copied!